Scholars Central

Conference abstractPublished 22 Oct 2018

Neonatal clinical pharmacology

Authors: Karel Allegaert

Sophias Childrens Hospital, Netherlands

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Drug therapy is a very powerful tool to improve the medical outcome of neonates. Yet, caregivers still commonly prescribe drug formulations and dosing regimens that initially were developed for adults, by extrapolating from indications documented in adult medicine and based on the pathophysiology proper to the adult patient. Human growth and development consists of a sequence of physiologic events that relate to both somatic growth as well as (neurobehavioral) maturation since weight gain co-exists but is not similar to maturation. These maturational physiological trends are further affected by either treatment modalities [e.g. whole body cooling, extracorporeal membrane oxygenation (ECMO) or pharmacotherapy] used or pathophysiological processes or co-morbidities [e.g. perinatal asphyxia, cardiopathy, sepsis, renal failure, patent ductus arteriosus]. All these changes, both maturational (e.g. age, weight) and pathophysiological result in extensive variability within the first months of postnatal life and make neonatal pharmacotherapy as diverse as the neonates taken care for in our units. The aim of administering any compound is to reach effective treatment of a given disease while avoiding disproportional sideeffects. Clinical pharmacology aims to predict drug-specific (side)-effects based on pharmacokinetics and pharmacodynamics. Pharmacokinetics (PK, absorption, distribution and subsequent elimination, either through metabolic elimination or through primary renal elimination, ADME) hereby estimate the relationship between a drug concentration at a specific site (e.g. plasma, cerebrospinal fluid) and time (â??what the body does to the drugâ??). Pharmacodynamics (PD) estimates the relationship between a drug concentration and (side)-effects (â??what the drug does to the bodyâ??)

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pediatrics & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPediatrics & Therapeutics
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Karel Allegaert”